14. Renal denervation

Ultrasound renal denervation for hypertension

RADIANCE-HTN-TRIO
Objective
to report the clinical outcome of ultrasound renal denervation compared to sham procedure in patients with three or more antihypertensive medications (including diuretic)
Study
international, single-blind, sham-controlled, multicentre randomised trial
Population
patients (18-75 years) office blood pressure at least 140/90 mmHg despite intensive treatment. Eligible patients: switched to once daily single pill combination of calcium channel blocker, angiotensin receptor blocker and thiazide diuretic. Then patients with daytime ambulatory blood pressure of at least 135/85 mmHg were studied
Endpoints
change in daytime ambulatory systolic blood pressure at 2 months
Conclusion
ultrasound renal denervation reduced blood pressure at 2 months compared to sham procedure in patients with hypertension resistant to triple antihypertensive medications
Azizi et al. Lancet. 2021;397:2476-86
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved